Related Experiment Video
Updated: Jun 30, 2026
08:34
Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat
Published on: November 18, 2018
[Pulmonary hypertension in lung diseases]
1Medizinische Klinik und Poliklinik I, Schwerpunkt Pneumologie, Klinikum der LMU, Campus Grosshadern, München. Juergen.Behr@med.uni-muenchen.de
Deutsche Medizinische Wochenschrift (1946)
|October 1, 2008
Summary
Diagnosing pulmonary hypertension (PH) in lung disease patients is challenging due to shared symptoms. While specific PAH medications aren't approved, off-label use may be considered, pending further trials.
Area of Science:
- Pulmonology
- Cardiology
Context:
- Pulmonary hypertension (PH) frequently complicates obstructive and restrictive lung diseases.
- Early PH detection in lung disease patients is difficult due to overlapping clinical symptoms.
Purpose:
- To review diagnostic challenges and therapeutic strategies for pulmonary hypertension in patients with underlying lung diseases.
- To highlight the need for further research into specific PH therapies for lung disease-associated PH.
Summary:
- Clinical symptoms like dyspnea, hypoxemia, and elevated BNP/NT-proBNP can suggest PH.
- Right heart catheterization remains the gold standard for PH diagnosis.
- Treatment focuses on the underlying lung disease and oxygen therapy; lung transplantation is an option for eligible patients.
Impact:
- Current treatments for lung disease-associated PH primarily involve managing the underlying condition.
- Specific pulmonary arterial hypertension (PAH) medications are not FDA-approved for this indication.
- Off-label use of PAH therapies may be considered, but robust clinical trials are needed to establish efficacy and safety.
Related Concept Videos
01:30Pulmonary Hypertension: Classification and Pathogenesis
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:17Other Pulmonary Disorders
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
01:16Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
01:18Pulmonary Edema II: Pathophysiology
Pulmonary edema is the accumulation of fluid in the interstitial and alveolar spaces of the lungs, impairing gas exchange and oxygen delivery. It may be cardiogenic or noncardiogenic, but both reduce oxygenation and lung compliance.Cardiogenic Pulmonary EdemaCardiogenic edema results from increased hydrostatic pressure in pulmonary capillaries, usually due to left ventricular dysfunction from myocardial infarction, heart failure, or valvular disease. Ineffective cardiac pumping causes blood to...
01:22Portal Hypertension
Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...